Voya Financial Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $474K | Sell |
2,494
-452
| -15% | -$87.2K | 0.05% | 136 |
|
|
2025
Q4 | $545K | Sell |
2,946
-399
| -12% | -$70K | 0.05% | 138 |
|
|
2025
Q3 | $496K | Sell |
3,345
-422
| -11% | -$63.9K | 0.05% | 146 |
|
|
2025
Q2 | $526K | Sell |
3,767
-194
| -5% | -$27.2K | 0.05% | 149 |
|
|
2025
Q1 | $585K | Sell |
3,961
-125
| -3% | -$18.1K | 0.06% | 128 |
|
|
2024
Q4 | $536K | Sell |
4,086
-1,258
| -24% | -$176K | 0.06% | 147 |
|
|
2024
Q3 | $830K | Sell |
5,344
-586
| -10% | -$94.6K | 0.09% | 105 |
|
|
2024
Q2 | $927K | Sell |
5,930
-82
| -1% | -$12.3K | 0.1% | 91 |
|
|
2024
Q1 | $821K | Buy |
6,012
+64
| +1% | +$8.47K | 0.09% | 102 |
|
|
2023
Q4 | $801K | Buy |
5,948
+85
| +1% | +$11.1K | 0.1% | 100 |
|
|
2023
Q3 | $791K | Sell |
5,863
-226
| -4% | -$30.9K | 0.1% | 91 |
|
|
2023
Q2 | $863K | Buy |
6,089
+23
| +0.4% | +$3.38K | 0.1% | 84 |
|
|
2023
Q1 | $840K | Buy |
6,066
+214
| +4% | +$28.8K | 0.1% | 88 |
|
|
2022
Q4 | $797K | Buy |
5,852
+734
| +14% | +$92K | 0.1% | 100 |
|
|
2022
Q3 | $562K | Buy |
5,118
+233
| +5% | +$29.6K | 0.07% | 128 |
|
|
2022
Q2 | $655K | Buy |
4,885
+888
| +22% | +$117K | 0.08% | 112 |
|
|
2022
Q1 | $536K | Buy |
3,997
+1,646
| +70% | +$197K | 0.06% | 152 |
|
|
2021
Q4 | $275K | Buy |
+2,351
| New | +$277K | 0.03% | 227 |
|
|
2021
Q2 | – | Sell |
-4,126
| Closed | -$412K | – | 277 |
|
|
2021
Q1 | $412K | Sell |
4,126
-3,716
| -47% | -$374K | 0.02% | 470 |
|
|
2020
Q4 | $787K | Sell |
7,842
-494
| -6% | -$52.3K | 0.03% | 309 |
|
|
2020
Q3 | $919K | Buy |
8,336
+2,138
| +34% | +$238K | 0.05% | 264 |
|
|
2020
Q2 | $656K | Buy |
6,198
+77
| +1% | +$7.95K | 0.03% | 311 |
|
|
2020
Q1 | $545K | Buy |
6,121
+2,028
| +50% | +$191K | 0.03% | 323 |
|
|
2019
Q4 | $409K | Buy |
4,093
+338
| +9% | +$31.8K | 0.02% | 437 |
|
|
2019
Q3 | $340K | Buy |
3,755
+132
| +4% | +$11.4K | 0.02% | 459 |
|
|
2019
Q2 | $297K | Buy |
3,623
+30
| +0.8% | +$2.35K | 0.02% | 493 |
|
|
2019
Q1 | $309K | Sell |
3,593
-5,340
| -60% | -$421K | 0.02% | 475 |
|
|
2018
Q4 | $675K | Sell |
8,933
-669
| -7% | -$52.2K | 0.05% | 258 |
|
|
2018
Q3 | $763K | Sell |
9,602
-6,091
| -39% | -$461K | 0.04% | 275 |
|
|
2018
Q2 | $1.09M | Sell |
15,693
-3,474
| -18% | -$250K | 0.07% | 211 |
|
|
2018
Q1 | $1.35M | Buy |
19,167
+489
| +3% | +$33.9K | 0.09% | 191 |
|
|
2017
Q4 | $1.27M | Buy |
18,678
+3,667
| +24% | +$247K | 0.08% | 204 |
|
|
2017
Q3 | $1M | Buy |
15,011
+4,227
| +39% | +$267K | 0.07% | 226 |
|
|
2017
Q2 | $736K | Buy |
10,784
+1,586
| +17% | +$104K | 0.05% | 250 |
|
|
2017
Q1 | $576K | Buy |
9,198
+3,673
| +66% | +$214K | 0.04% | 266 |
|
|
2016
Q4 | $302K | Buy |
5,525
+1,590
| +40% | +$90.3K | 0.03% | 358 |
|
|
2016
Q3 | $260K | Buy |
+3,935
| New | +$257K | 0.03% | 356 |
|
Other funds holding AZN
IA
VCM
VAM
Voya Financial Advisors's AZN Position: Q1 2026 in Review
Voya Financial Advisors reduced its AstraZeneca (AZN) stake by 15% in Q1 2026, selling an estimated $87.2K and leaving 2,494 shares worth $474K. The position accounts for 0.05% of the portfolio, ranked #136.
Voya Financial Advisors first reported a position in AZN in Q3 2016 and has held it in 37 quarters since. The position peaked at $1.35M in Q1 2018. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- Voya Financial Advisors held 2,494 shares of AstraZeneca worth $474K as of Q1 2026.
- Voya Financial Advisors sold 452 AstraZeneca shares in Q1 2026, an estimated $87.2K.
- AstraZeneca made up 0.05% of Voya Financial Advisors's portfolio in Q1 2026, its #136 holding.
- Voya Financial Advisors first reported a position in AstraZeneca in Q3 2016 and has held it in 37 quarters since.
- Voya Financial Advisors's AstraZeneca position peaked at $1.35M in Q1 2018.
- 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on Voya Financial Advisors's 13F filing for Q1 2026, filed 12 May 2026.